附註:Includes bibliographical references and index.
Introduction : Public pharmaceutical expenditure / J. Puig-Junoy -- Incentives for innovation in the pharmaceutical market / P. Ibern Regàs -- Price regulation systems in the pharmaceutical market / J. Puig-Junoy -- Regulation and competition in pharmaceutical markets / J.R. Borrell Arqué, A. Costas Comesaña and R. Nonell Torres -- Mechanisms to encourage price competition in the pharmaceutical market and their effects on efficiency and welfare / J. Rovira Forns and J. Darbà Coll -- Reference pricing as a pharmaceutical reimbursement mechanism / G. López-Casasnovas and J. Puig-Junoy -- Insurance in public financing of pharmaceuticals / B. González López-Valcàrcel -- Economic evaluation and pharmaceutical policy / J.L. Pinto Prades and X. Badía Llach -- Prescriber incentives / L. Cabiedes and V. Ortún -- Economic considerations regarding pharmaceutical expenditures in Spain and its financing / G. López-Casasnovas -- Review of economic studies of the pharmaceutical industry published over the last 20 years by Spanish economists / F. Lobo, M. Cabañas Sáenz and R. González Pérez -- Appendix : List of economic studies of the pharmaceutical industry and pharmaceuticals published over the last 20 years by Spanish economists.
摘要:This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.
